If any more evidence were needed of a bounceback in venture financing for biotechs after a dip in 2023, the $400 million first round just announced by Mirador Therapeutics should suffice.

Besides exploring the Alhambra, visitors to Granada should also take in the panoramic views from viewpoints like the Mirador de San Nicolas and the Mirador de Sacromonte. Another notable landmark is ...